Home › Digestive Diseases › Maryland › Baltimore
Digestive Diseases clinical trials in Baltimore, MD
4 studies for Digestive Diseases are looking for participants at sites in and around Baltimore (within about 30 miles). Open a study to see who can join and how to contact the study team.
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecruitingPhase 3
- Greater Baltimore Medical Center, Baltimore
Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions
RecruitingPhase 2
- University of Maryland, Baltimore
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
RecruitingPhase 3
- 89bio Clinical Study Site, Baltimore
- 89bio Clinical Study Site, Glen Burnie · 9 mi away
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
RecruitingPhase 3
- 89bio Clinical Study Site, Baltimore
- 89bio Clinical Study Site, Glen Burnie · 9 mi away
About Digestive Diseases
Learn about digestive disorders and how your gastrointestinal (GI) system works. Find out what tests you need in case you sense a problem.
More about Digestive Diseases on MedlinePlus
Digestive Diseases trials in other cities
- Houston, TX8 studies
- New York City, NY8 studies
- Chicago, IL8 studies
- Washington, DC6 studies
- Durham, NC6 studies
- Boston, MA6 studies
- San Diego, CA6 studies
- Rochester, MN5 studies
- San Antonio, TX5 studies
- St. Louis, MO5 studies
- Chandler, AZ5 studies
- Cincinnati, OH5 studies
Other studies in Baltimore
- Non-Small Cell Lung Cancer60 studies
- Breast Cancer47 studies
- Prostate Cancer42 studies
- Lung Cancer40 studies
- Cancer (all types)38 studies
- Pancreatic Cancer32 studies
- Colorectal Cancer31 studies
- Metastatic Cancer28 studies
- Obesity25 studies
- Bladder Cancer24 studies
- Heart Failure24 studies
- Stroke22 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.